Table 2.
WL (n = 21) | AEX (n = 20) | |||
---|---|---|---|---|
Pre | Post | Pre | Post | |
Age, y | 60 ± 1 | – | 62 ± 2 | – |
Body weight, kg | 102.9 ± 3.9 | 93.7 ± 3.5g,a | 92.7 ± 3.6 | 91.5 ± 4.1 |
BMI | 36 ± 1 | 33 ± 1c,a | 32 ± 1 | 32 ± 1 |
VO2max, L/min | 2.3 ± 0.1 | 2.3 ± 0.1a | 2.4 ± 0.1 | 2.7 ± 0.1g |
VO2max, mL/kg/min | 23.0 ± 1.2 | 24.6 ± 1.3e,a | 25.1 ± 1.1 | 29.2 ± 1.3e |
VO2max, mL/kgFFM/min | 40.0 ± 1.0 | 40.0 ± 1.1 | 41.7 ± 1.47 | 44.4 ± 3.0 |
% Body fat | 44.2 ± 1.7 | 41.2 ± 2.0g | 38.3 ± 1.8 | 36.9 ± 2.1d |
Fat mass, kg | 45.7 ± 2.5 | 38.9 ± 2.4g,a | 36.3 ± 2.5 | 35.0 ± 2.9 |
FFM, kg | 57.4 ± 2.8 | 55.9 ± 2.7g,a | 57.6 ± 2.4 | 58.4 ± 2.6c |
Fasting glucose, mg/dL | 101 ± 3 | 92 ± 2g,b | 96 ± 2 | 95 ± 2 |
120-min glucose, mg/dL | 150 ± 10 | 128 ± 9e | 131 ± 9 | 127 ± 9 |
Fasting insulin, pmol/L | 109 ± 11 | 85 ± 8f | 100 ± 9 | 90 ± 9a |
120-min insulin, pmol/L | 685 ± 93 | 472 ± 57f | 595 ± 92 | 505 ± 56 |
M, μmol.kg–1.min–1 | 22.1 ± 2.9 | 31.2 ± 2.8e | 31.7 ± 2.6 | 37.3 ± 2.8c |
M, μmol.kgFFM–1.min–1 | 40.8 ± 4.6 | 55.2 ± 4.7d | 52.2 ± 4.7 | 59.6 ± 5.1c |
HOMA-IR | 4.0 ± 0.5 | 2.8 ± 0.3e | 3.4 ± 0.3 | 3.1 ± 0.3 |
All participants (n = 41) before and after the AEX (n = 20) and WL (n = 21) intervention. Values are mean ± SEM.
Abbreviations: AEX, aerobic exercise; BMI, body mass index; FFM, fat free mass; HOMA-IR, homeostatic model assessment of insulin resistance; VO2max, maximal oxygen consumption; WL, weight loss.
Statistically significant different pre and post intervention WL vs AEX:
a P < .001;
b P < .05;
c P ≤ .05;
d P < .01;
e P < .001;
f P˂.005; and
g P ≤ .0001.